Thus, MSLN’s observed effect on pancreatic cancer cell proliferation in vitro4 may partly be mediated by RARγ and its ability to regulate the balance of self-renewal and differentiation depending on the concentrations of retinoids present. The gene discussed is RARG; the disease is pancreatic neoplasm.